BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17174194)

  • 1. Insulin resistance as a determinant of platelet activation in obese women.
    Basili S; Pacini G; Guagnano MT; Manigrasso MR; Santilli F; Pettinella C; Ciabattoni G; Patrono C; Davì G
    J Am Coll Cardiol; 2006 Dec; 48(12):2531-8. PubMed ID: 17174194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus.
    Santilli F; Davì G; Consoli A; Cipollone F; Mezzetti A; Falco A; Taraborelli T; Devangelio E; Ciabattoni G; Basili S; Patrono C
    J Am Coll Cardiol; 2006 Jan; 47(2):391-7. PubMed ID: 16412866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet activation in obese women: role of inflammation and oxidant stress.
    Davì G; Guagnano MT; Ciabattoni G; Basili S; Falco A; Marinopiccoli M; Nutini M; Sensi S; Patrono C
    JAMA; 2002 Oct 23-30; 288(16):2008-14. PubMed ID: 12387653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of platelet activation in Alzheimer's disease.
    Ciabattoni G; Porreca E; Di Febbo C; Di Iorio A; Paganelli R; Bucciarelli T; Pescara L; Del Re L; Giusti C; Falco A; Sau A; Patrono C; Davì G
    Neurobiol Aging; 2007 Mar; 28(3):336-42. PubMed ID: 16442186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased thromboxane biosynthesis in essential thrombocythemia.
    Rocca B; Ciabattoni G; Tartaglione R; Cortelazzo S; Barbui T; Patrono C; Landolfi R
    Thromb Haemost; 1995 Nov; 74(5):1225-30. PubMed ID: 8607099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
    Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A
    Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous secretory RAGE in obese women: association with platelet activation and oxidative stress.
    Vazzana N; Guagnano MT; Cuccurullo C; Ferrante E; Lattanzio S; Liani R; Romano M; Davì G
    J Clin Endocrinol Metab; 2012 Sep; 97(9):E1726-30. PubMed ID: 22761461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helicobacter pylori infection causes persistent platelet activation in vivo through enhanced lipid peroxidation.
    Davì G; Neri M; Falco A; Festi D; Taraborelli T; Ciabattoni G; Basili S; Cuccurullo F; Patrono C
    Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):246-51. PubMed ID: 15472127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular risk factors in obese women and their first-degree relatives.
    Saraç F; Ozgen AG; Yilmaz C; Tüzün M
    Anadolu Kardiyol Derg; 2007 Dec; 7(4):371-7. PubMed ID: 18065331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased thromboxane metabolites excretion in liver cirrhosis.
    Davì G; Ferro D; Basili S; Iuliano L; Camastra C; Giammarresi C; Santarone S; Rocca B; Landolfi R; Ciabattoni G; Cordova C; Violi F
    Thromb Haemost; 1998 Apr; 79(4):747-51. PubMed ID: 9569186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance induced by hydrocortisone is increased in patients with abdominal obesity.
    Darmon P; Dadoun F; Boullu-Ciocca S; Grino M; Alessi MC; Dutour A
    Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E995-E1002. PubMed ID: 16772320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thromboxane production in morbidly obese subjects.
    Graziani F; Biasucci LM; Cialdella P; Liuzzo G; Giubilato S; Della Bona R; Pulcinelli FM; Iaconelli A; Mingrone G; Crea F
    Am J Cardiol; 2011 Jun; 107(11):1656-61. PubMed ID: 21439532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity.
    Hung J; McQuillan BM; Thompson PL; Beilby JP
    Int J Obes (Lond); 2008 May; 32(5):772-9. PubMed ID: 18253163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration.
    Davì G; Chiarelli F; Santilli F; Pomilio M; Vigneri S; Falco A; Basili S; Ciabattoni G; Patrono C
    Circulation; 2003 Jul; 107(25):3199-203. PubMed ID: 12810609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High plasma C-reactive protein (CRP) is related to low paraoxonase-I (PON-I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus.
    Dullaart RP; de Vries R; Sluiter WJ; Voorbij HA
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):221-6. PubMed ID: 18505467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. sP-selectin plasma levels in obesity: association with insulin resistance and related metabolic and prothrombotic factors.
    De Pergola G; Pannacciulli N; Coviello M; Scarangella A; Di Roma P; Caringella M; Venneri MT; Quaranta M; Giorgino R
    Nutr Metab Cardiovasc Dis; 2008 Mar; 18(3):227-32. PubMed ID: 17400434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of weight loss on coronary circulation and adiponectin levels in obese women.
    Coppola A; Marfella R; Coppola L; Tagliamonte E; Fontana D; Liguori E; Cirillo T; Cafiero M; Natale S; Astarita C
    Int J Cardiol; 2009 May; 134(3):414-6. PubMed ID: 18378021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome.
    Guzelmeric K; Alkan N; Pirimoglu M; Unal O; Turan C
    Gynecol Endocrinol; 2007 Sep; 23(9):505-10. PubMed ID: 17852421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet activation markers in patients with peripheral arterial disease--a prospective comparison of different platelet function tests.
    Gresele P; Catalano M; Giammarresi C; Volpato R; Termini R; Ciabattoni G; Nenci GG; Davì G
    Thromb Haemost; 1997 Dec; 78(6):1434-7. PubMed ID: 9423790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-beta2 glycoprotein I antibodies and platelet activation in patients with antiphospholipid antibodies: association with increased excretion of platelet-derived thromboxane urinary metabolites.
    Forastiero R; Martinuzzo M; Carreras LO; Maclouf J
    Thromb Haemost; 1998 Jan; 79(1):42-5. PubMed ID: 9459320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.